Literature DB >> 35987945

Explaining the interaction of mangiferin with MMP-9 and NF-ƙβ: a computational study.

Andy Gálvez-Rodríguez1, Anthuan Ferino-Pérez2, Zalua Rodríguez-Riera1, Idania Rodeiro Guerra3, David Řeha4, Babak Minofar4, Ulises J Jáuregui-Haza5.   

Abstract

Mangiferin is a glycosylated xanthone widely distributed in nature, which exhibits wide pharmacological activities, highlighting its anti-cancer properties. Mangiferin interferes with inflammation, lipid, and calcium signaling, which selectively inhibits multiple NFkB target genes as interleukin-6, tumor necrosis factor, plasminogen, and matrix metalloproteinase, among others. In this work, the interactions of this polyphenol with MMP-9 and NF-κβ are characterized by using computational chemistry methods. The results show MMP-9 inhibition by mangiferina is characterized for the interact with the catalytic Zn atom through a penta-coordinate structure. It is also demonstrated through a strong charge transfer established between mangiferin and Zn in the QM/MM study. Concerning the mangiferin/NF-κβ system, the 92.3% of interactions between p50 sub-unity and DNA are maintained with a binding energy of - 8.04 kcal/mol. These findings indicate that mangiferin blocks the p50-p65/DNA interaction resulting in the loss of the functions of this hetero-dimeric member and suggesting inhibition of the cancer progression. Experimental results concerning the anti-cancer properties of mangiferin show that this natural compound can inhibit selectively MMP-9 and NF-ƙβ. Although the anti-tumor properties of mangiferin are well defined, its molecular mechanisms of actions are not described. In this work, a computational study is carried out to characterize the interactions of mangiferin with these molecular targets. The results obtained corroborate the anti-proliferative and anti-apoptotic activity of mangiferin and provide a depiction of its mechanisms of action.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Anti-cancer activity; Mangiferin; Molecular docking; Natural bond analysis; QM/MM

Mesh:

Substances:

Year:  2022        PMID: 35987945     DOI: 10.1007/s00894-022-05260-2

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   2.172


  35 in total

1.  Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9.

Authors:  Antoine Dufour; Nicole S Sampson; Jian Li; Cem Kuscu; Robert C Rizzo; Jennifer L Deleon; Jizu Zhi; Nadia Jaber; Eric Liu; Stanley Zucker; Jian Cao
Journal:  Cancer Res       Date:  2011-06-06       Impact factor: 12.701

2.  Analgesic and antioxidant activity of mangiferin and its derivatives: the structure activity relationship.

Authors:  Ahsana Dar; Shaheen Faizi; Sabira Naqvi; Talat Roome; Sadia Zikr-ur-Rehman; Muhammad Ali; Sadiqa Firdous; Syed Tarique Moin
Journal:  Biol Pharm Bull       Date:  2005-04       Impact factor: 2.233

3.  Protective effect of Mangifera indica L. polyphenols on human T lymphocytes against activation-induced cell death.

Authors:  Patricia Hernandez; Pedro C Rodriguez; Rene Delgado; Henning Walczak
Journal:  Pharmacol Res       Date:  2006-11-19       Impact factor: 7.658

4.  Vascular effects of the Mangifera indica L. extract (Vimang).

Authors:  Amada E Beltrán; Yolanda Alvarez; Fabiano E Xavier; Raquel Hernanz; Janet Rodriguez; Alberto J Núñez; María J Alonso; Mercedes Salaices
Journal:  Eur J Pharmacol       Date:  2004-09-24       Impact factor: 4.432

5.  New antidiabetic compounds, mangiferin and its glucoside.

Authors:  H Ichiki; T Miura; M Kubo; E Ishihara; Y Komatsu; K Tanigawa; M Okada
Journal:  Biol Pharm Bull       Date:  1998-12       Impact factor: 2.233

6.  Molecular docking and synthesis of novel quinazoline analogues as inhibitors of transcription factors NF-κB activation and their anti-cancer activities.

Authors:  Lu Xu; Wade A Russu
Journal:  Bioorg Med Chem       Date:  2012-11-15       Impact factor: 3.641

7.  In vivo and in vitro anti-inflammatory activity of Mangifera indica L. extract (VIMANG).

Authors:  Gabino Garrido; Deyarina González; Yeny Lemus; Dagmar García; Lizt Lodeiro; Gypsy Quintero; Carla Delporte; Alberto J Núñez-Sellés; René Delgado
Journal:  Pharmacol Res       Date:  2004-08       Impact factor: 7.658

Review 8.  Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview.

Authors:  Subha Mondal; Nilanjan Adhikari; Suvankar Banerjee; Sk Abdul Amin; Tarun Jha
Journal:  Eur J Med Chem       Date:  2020-03-21       Impact factor: 6.514

9.  NF-κB in cancer: a matter of life and death.

Authors:  Bharat B Aggarwal; Bokyung Sung
Journal:  Cancer Discov       Date:  2011-11       Impact factor: 39.397

10.  Ligand-based pharmacophore modeling and molecular dynamic simulation approaches to identify putative MMP-9 inhibitors.

Authors:  Bharat Kumar Reddy Sanapalli; Vidyasrilekha Yele; Srikanth Jupudi; Veera Venkata Satyanarayana Reddy Karri
Journal:  RSC Adv       Date:  2021-08-06       Impact factor: 4.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.